Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Benson, AB; Venook, AP; Adam, M; Chang, G; Chen, Y-J; Ciombor, KK; Cohen, SA; Cooper, HS; Deming, D; Garrido-Laguna, I; Grem, JL; Haste, P ...
Published in: J Natl Compr Canc Netw
June 2024
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data supporting the systemic therapy options recommended for metastatic CRC in the NCCN Guidelines for Colon Cancer.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2024
Volume
22
Issue
2 D
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Colonic Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., Venook, A. P., Adam, M., Chang, G., Chen, Y.-J., Ciombor, K. K., … Jones, F. (2024). Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(2 D). https://doi.org/10.6004/jnccn.2024.0029
Benson, Al B., Alan P. Venook, Mohamed Adam, George Chang, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, et al. “Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 22, no. 2 D (June 2024). https://doi.org/10.6004/jnccn.2024.0029.
Benson AB, Venook AP, Adam M, Chang G, Chen Y-J, Ciombor KK, et al. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Jun;22(2 D).
Benson, Al B., et al. “Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 22, no. 2 D, June 2024. Pubmed, doi:10.6004/jnccn.2024.0029.
Benson AB, Venook AP, Adam M, Chang G, Chen Y-J, Ciombor KK, Cohen SA, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Haste P, Hecht JR, Hoffe S, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber JM, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Gurski LA, Snedeker J, Jones F. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Jun;22(2 D).
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2024
Volume
22
Issue
2 D
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Colonic Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis